Benchmark
Device Neurointervention
PDI 00814548014128
General payments
$232,447
Research payments
$20,000
Through program year 2025, $232,447 in general payments and $20,000 in research payments were reported against Benchmark (Neurointervention).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $39,097 | 126 |
| 2024 | General | $80,700 | 271 |
| 2023 | General | $86,328 | 826 |
| 2022 | General | $12,737 | 208 |
| 2021 | General | $13,585 | 231 |
| 2021 | Research | $20,000 | 1 |
Breakdown
The top 5 of 88 recipients; each share is of general payments naming this product in 2025.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,662 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.